1. Home
  2. OFIX vs TECX Comparison

OFIX vs TECX Comparison

Compare OFIX & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orthofix Medical Inc. (DE)

OFIX

Orthofix Medical Inc. (DE)

HOLD

Current Price

$12.24

Market Cap

473.3M

Sector

Health Care

ML Signal

HOLD

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$27.59

Market Cap

554.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
OFIX
TECX
Founded
1987
2019
Country
United States
United States
Employees
N/A
60
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
473.3M
554.1M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
OFIX
TECX
Price
$12.24
$27.59
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$17.25
$75.20
AVG Volume (30 Days)
211.9K
187.0K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
29.39
N/A
EPS
N/A
N/A
Revenue
$822,312,000.00
N/A
Revenue This Year
$6.13
N/A
Revenue Next Year
$6.22
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.85
N/A
52 Week Low
$10.25
$14.39
52 Week High
$16.99
$35.99

Technical Indicators

Market Signals
Indicator
OFIX
TECX
Relative Strength Index (RSI) 48.69 42.16
Support Level $10.94 $17.71
Resistance Level $12.99 $31.88
Average True Range (ATR) 0.42 1.47
MACD 0.01 -0.39
Stochastic Oscillator 45.83 19.78

Price Performance

Historical Comparison
OFIX
TECX

About OFIX Orthofix Medical Inc. (DE)

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: